GLP-1 weight loss drugs effective even at low starter doses
The GLP-1 drugs semaglutide, sold as Ozempic and Wegovy by Novo Nordisk, and Eli Lilly's tirzepatide, sold under the brand names Mounjaro and Zepbound, are prescribed initially at a low dose followed by gradual titration to higher doses, to help the body adjust and minimize side effects
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.thehindu.com — the content belongs to The Hindu - Sci-Tech.
